CSDX
CS Diagnostics Corp.
Price Chart
Latest Quote
$0.04
-0.01 (-16.80%)
Current Price
| Previous Close | $0.05 |
| Open | $0.04 |
| Day High | $0.04 |
| Day Low | $0.04 |
| Volume | 30,000 |
Stock Information
| Shares Outstanding | 249.99M |
| Cash Equivalents | $7K |
| Revenue | $204K |
| Net Income | $71K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $10.40M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $12.49M |
| Sales | $204K |
| Income | $71K |
| Book/sh | $2.00 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.45 |
| Current Ratio | 5.61 |
Returns & Margins
| ROA | 0.01% |
| ROE | 0.01% |
| Gross Margin | 100.00% |
| Operating Margin | 35.64% |
| Profit Margin | 34.91% |
Ownership
| Insider Ownership | 85.45% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 50.98 |
| P/B | 0.02 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.06 |
| SMA50 | $0.10 |
| SMA200 | $0.21 |
| RSI | 29.48 |
| ATR | 0.0139 |
| Shares Float | 46.06M |
| Volatility | -21.80 |
| Rel Volume | 0.35 |
Performance History
| Week | -24.36% |
| Month | -55.98% |
| Quarter | -68.55% |
| 6 Months | -83.29% |
| YTD | -86.13% |
| Year | -29.49% |
| 3 Years | -97.69% |
| 5 Years | -99.02% |
| 10 Years | -97.32% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $0.04 | 48,060 |
| 2026-06-16 | $0.05 | 2,000 |
| 2026-06-15 | $0.05 | 571,560 |
| 2026-06-12 | $0.05 | 29,000 |
| 2026-06-11 | $0.05 | 252 |
| 2026-06-10 | $0.05 | 36,773 |
| 2026-06-09 | $0.06 | 3,000 |
| 2026-06-08 | $0.07 | 1,300 |
| 2026-06-05 | $0.05 | 577 |
| 2026-06-04 | $0.06 | 7,188 |
| 2026-06-03 | $0.06 | 140,846 |
| 2026-06-02 | $0.08 | 964,222 |
| 2026-06-01 | $0.08 | 100 |
| 2026-05-29 | $0.06 | 135,839 |
| 2026-05-28 | $0.10 | 100 |
| 2026-05-27 | $0.06 | 38,600 |
| 2026-05-26 | $0.08 | 45,300 |
| 2026-05-22 | $0.06 | 511,761 |
| 2026-05-21 | $0.09 | 118,789 |
| 2026-05-20 | $0.08 | 81,043 |
| 2026-05-19 | $0.08 | 83,766 |
| 2026-05-18 | $0.09 | 147,550 |
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.
đ° Latest News
How Investors Are Reacting To FedEx (FDX) Freight Spin-Off And Shift Toward Higher-Value Logistics Services
Simply Wall St. âĸ 2026-01-25T22:06:44Z
CS Diagnostics Picks DHL for MEDUSA SDP Rollout Might Change The Case For Investing In Deutsche Post (XTRA:DHL)
Simply Wall St. âĸ 2026-01-25T22:06:41Z
Deutsche Post (XTRA:DHL) Valuation Check As DHL Wins CS Diagnostics Global MEDUSA SDP Logistics Role
Simply Wall St. âĸ 2026-01-25T13:06:09Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | ||
| Total Revenue | $0 | $0 |
| Operating Revenue | $0 | $0 |
| Expenses | ||
| Total Expenses | $-71,219 | $-761 |
| Operating Expense | $-71,219 | $-761 |
| Other Operating Expenses | $-204,000 | $-110,911 |
| General And Administrative Expense | $132,781 | $110,150 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $71,219 | $761 |
| Normalized Income | $71,219 | $761 |
| Net Income From Continuing And Discontinued Operation | $71,219 | $761 |
| Total Operating Income As Reported | $71,219 | $761 |
| Net Income Common Stockholders | $71,219 | $761 |
| Net Income | $71,219 | $761 |
| Net Income Including Noncontrolling Interests | $71,219 | $761 |
| Net Income Continuous Operations | $71,219 | $761 |
| Pretax Income | $71,219 | $761 |
| Operating Income | $71,219 | $761 |
| Per Share | ||
| Diluted EPS | - | $0.00 |
| Basic EPS | - | $0.00 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $71,219 | $761 |
| EBITDA (Bullshit earnings) | $71,219 | $761 |
| EBIT | $71,219 | $761 |
| Diluted NI Availto Com Stockholders | $71,219 | $761 |
| Selling General And Administration | $132,781 | $110,150 |
| Other Gand A | $132,781 | $110,150 |
| Diluted Average Shares | - | $137,290,200 |
| Basic Average Shares | - | $137,290,200 |
Fetched: 2026-04-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $70,293 | $-927 |
| Total Assets | $499,485,555 | $499,400,501 |
| Total Non Current Assets | $499,400,000 | $499,400,000 |
| Goodwill And Other Intangible Assets | $499,400,000 | $499,400,000 |
| Current Assets | $85,555 | $501 |
| Cash Cash Equivalents And Short Term Investments | $85,555 | $501 |
| Cash And Cash Equivalents | $6,813 | $501 |
| Cash Financial | $6,813 | $501 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $15,262 | $1,428 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 |
| Current Liabilities | $15,262 | $1,428 |
| Payables And Accrued Expenses | $15,262 | $1,428 |
| Payables | $15,262 | $1,428 |
| Accounts Payable | $15,262 | $1,428 |
| Equity | ||
| Common Stock Equity | $499,468,265 | $499,397,073 |
| Preferred Stock Equity | $2,028 | $2,000 |
| Total Equity Gross Minority Interest | $499,470,293 | $499,399,073 |
| Stockholders Equity | $499,470,293 | $499,399,073 |
| Retained Earnings | $-4,696,710 | $-4,767,929 |
| Other | ||
| Ordinary Shares Number | $249,992,200 | $137,290,200 |
| Share Issued | $249,992,200 | $137,290,200 |
| Tangible Book Value | $68,265 | $-2,927 |
| Invested Capital | $499,468,265 | $499,397,073 |
| Working Capital | $70,293 | $-927 |
| Total Capitalization | $499,470,293 | $499,399,073 |
| Additional Paid In Capital | $504,162,475 | $504,163,629 |
| Capital Stock | $4,528 | $3,373 |
| Common Stock | $2,500 | $1,373 |
| Preferred Stock | $2,028 | $2,000 |
| Other Short Term Investments | $78,742 | $0 |
Fetched: 2026-04-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $6,312 | $11,031 |
| Operating Activities | ||
| Operating Cash Flow | $6,312 | $11,031 |
| Cash Flow From Continuing Operating Activities | $6,311 | $11,031 |
| Investing Activities | ||
| Investing Cash Flow | $0 | $0 |
| Financing Activities | ||
| Financing Cash Flow | $0 | $0 |
| Other | ||
| End Cash Position | $6,813 | $11,031 |
| Beginning Cash Position | $501 | $0 |
| Changes In Cash | $6,312 | $11,031 |
| Change In Working Capital | $-64,908 | $10,270 |
| Change In Payables And Accrued Expense | $13,834 | $1,428 |
| Change In Payable | $13,834 | $1,428 |
| Change In Account Payable | $13,834 | $1,428 |
| Change In Receivables | $-78,742 | $8,842 |
| Other Non Cash Items | $1 | - |
| Net Income From Continuing Operations | $71,219 | $761 |
Fetched: 2026-04-23